 |
AbbVie
ABBV
|
226 |
$ 263.04 |
0.49 % |
$ 465 B |
USA |
 |
AbCellera Biologics
ABCL
|
3.22 |
$ 11.41 |
2.15 % |
$ 3.41 B |
Canada |
 |
Aclaris Therapeutics
ACRS
|
3.14 |
$ 5.53 |
6.02 % |
$ 678 M |
USA |
 |
ADC Therapeutics SA
ADCT
|
1.09 |
$ 1.09 |
3.74 % |
$ 139 M |
Schweiz |
 |
Amryt Pharma plc
AMYT
|
10.8 |
- |
- |
$ 621 M |
Britain |
 |
Evelo Biosciences
EVLO
|
0.31 |
- |
-14.46 % |
$ 27.9 M |
USA |
 |
Allakos
ALLK
|
1.31 |
- |
- |
$ 28.6 M |
USA |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 |
- |
- |
$ 231 M |
USA |
 |
Clovis Oncology
CLVS
|
2.04 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Chimerix
CMRX
|
1.17 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
3.03 |
- |
- |
$ 401 M |
USA |
 |
ADMA Biologics
ADMA
|
15.9 |
$ 8.61 |
0.16 % |
$ 2.05 B |
USA |
 |
Eiger BioPharmaceuticals
EIGR
|
2.11 |
- |
-9.21 % |
$ 2.55 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.4 |
- |
- |
$ 384 M |
Britain |
 |
Fusion Pharmaceuticals
FUSN
|
21.1 |
- |
- |
$ 1.41 B |
Canada |
 |
Guardion Health Sciences
GHSI
|
6.33 |
- |
-0.31 % |
$ 3.64 M |
USA |
 |
Genocea Biosciences
GNCA
|
1.06 |
- |
-15.0 % |
$ 3.04 M |
USA |
 |
Gritstone Oncology
GRTS
|
2.39 |
- |
0.42 % |
$ 213 M |
USA |
 |
G1 Therapeutics
GTHX
|
3.35 |
- |
- |
$ 370 M |
USA |
 |
Harpoon Therapeutics
HARP
|
0.65 |
- |
- |
$ 763 M |
USA |
 |
Humanigen
HGEN
|
0.14 |
- |
-81.12 % |
$ 4.28 M |
USA |
 |
HOOKIPA Pharma
HOOK
|
0.71 |
- |
-6.92 % |
$ 79.4 M |
USA |
 |
Intercept Pharmaceuticals
ICPT
|
20.9 |
- |
- |
$ 643 M |
USA |
 |
IGM Biosciences
IGMS
|
1.4 |
- |
- |
$ 76.9 M |
USA |
 |
IMV
IMV
|
0.82 |
- |
- |
$ 13.1 M |
Canada |
 |
Intra-Cellular Therapies
ITCI
|
129 |
- |
- |
$ 13.6 B |
USA |
 |
Kinnate Biopharma
KNTE
|
2.66 |
- |
- |
$ 123 M |
USA |
 |
Chinook Therapeutics
KDNY
|
21.6 |
- |
- |
$ 2.6 B |
USA |
 |
Kaleido Biosciences
KLDO
|
1.76 |
- |
-3.69 % |
$ 12.4 M |
USA |
 |
Kronos Bio
KRON
|
1.2 |
- |
1.49 % |
$ 50.8 M |
USA |
 |
Karuna Therapeutics
KRTX
|
319 |
- |
- |
$ 12.2 B |
USA |
 |
Landos Biopharma
LABP
|
7.67 |
- |
0.58 % |
$ 144 M |
USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
4.63 |
- |
- |
$ 154 M |
USA |
 |
LogicBio Therapeutics
LOGC
|
2.31 |
- |
- |
$ 229 M |
USA |
 |
Lumos Pharma
LUMO
|
3.02 |
- |
- |
$ 35.3 M |
USA |
 |
Merrimack Pharmaceuticals
MACK
|
14.8 |
- |
- |
$ 216 M |
USA |
 |
Stealth BioTherapeutics Corp
MITO
|
0.66 |
- |
- |
$ 23.9 M |
USA |
 |
Mirati Therapeutics
MRTX
|
45.6 |
- |
- |
$ 3.3 B |
USA |
 |
NexImmune
NEXI
|
3.47 |
- |
70.13 % |
$ 4.12 M |
USA |
 |
9 Meters Biopharma
NMTR
|
1.35 |
- |
-42.97 % |
$ 1.05 M |
USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
2.05 |
- |
-37.48 % |
$ 476 K |
USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
0.2 |
- |
-19.68 % |
$ 18.4 M |
Canada |
 |
ObsEva SA
OBSV
|
1.99 |
- |
-15.52 % |
$ 10.5 M |
Schweiz |
 |
Oncorus
ONCR
|
0.33 |
- |
-8.54 % |
$ 3.19 M |
USA |
 |
OncoSec Medical Incorporated
ONCS
|
0.45 |
- |
31.87 % |
$ 1.61 M |
USA |
 |
Oncternal Therapeutics
ONCT
|
9.29 |
- |
-24.12 % |
$ 1.56 M |
USA |
 |
Opiant Pharmaceuticals
OPNT
|
26.2 |
- |
- |
$ 109 M |
USA |
 |
Orchard Therapeutics plc
ORTX
|
5.25 |
- |
1.02 % |
$ 90.8 M |
Britain |